Fig. 1. Effect of Cisplatin on expression of Fas and cell viability in sensitive and resistant ovarian cancer cell lines. (A-C) Expression of Fas in sensitive ovarian cancer cell lines A2780, SKOV3 and 8910 after treated with Cisplatin in in 0, 10, 20 μM (*P ＜ 0.05, **P ＜ 0.01, compared with 0). (D) Cell viability of A2780, SKOV3 and 8910 after treated with Cisplatin in 0, 10, 20 μM (*P ＜ 0.05, compared with 0). (E) Expression of Fas in epithelial ovarian cancer cell line A2780 and A2780/CP cells after treated with Cisplatin (0, 10, 20 μM) for 48h. (**P ＜ 0.01, compared with A2780). (F) Comparation of cell viability of A2780 and A2780/CP cells treated with Cisplatin in different concentration.